Basic HTML Version
Hellenic Association of
Pharmaceutical Compa-
nies (SFEE), Dionysios
Filiotis, who stresses that
“the sector's companies
can become a growth driv-
er, attracting investment for
collaborations and the co-
production of medicinal
products from recognized
companies in Greece.
Such a strategy can turn
our country into a major
global hub of the pharma-
ceutical industry within the
next ten years.”
In this context, the Pharmaceutical Forum Team
that has been established in the ACCI, is expect-
ed to launch operations in order to facilitate the
next steps of the industry's companies in Greece.
The Social
Security Funds'
pharmaceutical
expenditure
This January, the pharma-
ceutical expenses incurred
by Greek social security
funds for medicines
administered
through
pharmacies amounted to
287 million euros, margin-
ally reduced to 285 million
euros in February. Given
that the government's tar-
gets for 2012 provide for
an average monthly expenditure of no more than
240 million euros, there has been a cost overrun
of 45 million euros per month, which, if sustained,
could lead by the end of the year to a 500 million
euro deviation from the target.
In 2011, the purchase of medicines from pharma-
Trade with Greece
73
”
“
Family expenditure for
the purchase of phar-
maceuticals represents
1.25% of the “house-
wife's basket”, whose
total value is estimated
at 2,065.11 euros.